CYTH
Cyclo Therapeutics, Inc. Common Stock
CYTH
CYTH
Delisted
CYTH was delisted on the 25th of March, 2025.
13 hedge funds and large institutions have $795K invested in Cyclo Therapeutics, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 0 closing their positions.
Holders
13
Holders Change
–
Holders Change %
0%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
6
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TRCT
1
Tower Research Capital (TRC)
New York
|
$4K |
| 2 |
2
Wells Fargo
San Francisco,
California
|
$4K |
Top Sellers
| 1 |
1
BlackRock
New York
|
$1K |
| 2 |
2
Renaissance Technologies
New York
|
$126K |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$2K |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$500K |
| 5 |
5
Morgan Stanley
New York
|
$1K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $500K | 253,765 | -1,300 | -0.5% |
|
|
2
Renaissance Technologies
New York
| $126K | 63,986 | -11,801 | -16% |
|
3
Geode Capital Management
Boston,
Massachusetts
| $96K | 48,316 | – | – |
|
4
State Street
Boston,
Massachusetts
| $57K | 28,300 | – | – |
|
|
5
Wells Fargo
San Francisco,
California
| $4K | 2,051 | +4 | +0.2% |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $4K | 2,270 | +762 | +51% |
|
|
7
UBS Group
Zurich,
Switzerland
| $2K | 793 | -1,498 | -65% |
|
8
Citigroup
New York
| $2K | 1,191 | -41 | -3% |
|
|
9
BlackRock
New York
| $1K | 362 | -17,841 | -98% |
|
|
10
Morgan Stanley
New York
| $1K | 443 | -60 | -12% |
|
|
IA
11
IFP Advisors
Tampa,
Florida
| $1K | 13 | – | – |
|
12
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | 746 | – | – |
|
13
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $0 | 100 | – | – |
|
|
CFGS
14
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|